Trial Profile

Analgesic Efficacy and Safety of Etoricoxib in Ear Nose Throat Surgery.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 10 May 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Etoricoxib (Primary)
Indications Postoperative pain
Focus Therapeutic Use

Most Recent Events

28 Apr 2012 Additional lead trial centre added as reported by European Clinical Trials Database record.
28 Apr 2012 Actual end date (Jan 2010) added as reported by European Clinical Trials Database record.
28 Apr 2012 New source identified and integrated (European Clinical Trials Database record EudraCT2007-004274-10).

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com